According to The Insight Partners market research study titled ‘Active Implantable Medical Devices Market to 2025 – Global Analysis and Forecasts by Product and End User, the global active implantable medical devices market was valued at US$ 22,096.9 Mn in 2017 and is estimated to reach US$ 39,026.9 Mn by 2025. The market is estimated to grow with a CAGR of 7.9% from 2018-2025. The report highlights the trends prevalent in the global active implantable medical devices market and the factors driving the market along with those that act as deterrents to its growth.
Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002232/
The increasing prevalence of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements & new product launches and large pool of geriatric population are the major factors that anticipated to propel the growth for the active implantable medical devices market in the forecast period. However, the high cost of products and procedures and high rate of product recalls is expected to act as major challenges hindering the market growth at certain extent.
Global active implantable medical devices market segmented into by product and end user. Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, neurostimulators, implantable hearing devices, ventricular assist devices and implantable heart monitors/insertable loop recorders. The implantable cardioverter defibrillators segment is further bifurcated into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. On the basis of end user, the active implantable medical devices market classified as hospitals, ambulatory surgery centers and specialty clinics.
The high market growth is anticipated on account of the rising global geriatric population. The risk of cardiovascular diseases increases with increase in age, in both male and females. Increasing age makes the blood vessels less flexible and reduction in blood flow. Thus, the risk of heart disease is high in elder population. According to the Heart Disease and Stroke Statistics 2018, average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that annual incidence of heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. Similarly, rising prevalence of the neurological disorders in the geriatric population is expected to serve as a high impact rendering driver for the active implantable medical devices market over the forecast period. According to the Alzheimer’s Association, in 2018, 5.7 million Americans suffer from Alzheimer’s dementia of which 5.5 million are people with age 65 and older. Furthermore, the United Nations in 2017, estimated 962 million people are aged 60 or over across the globe and is increasing by 3% every year. It also stated that the elder population with 60 and more age worldwide is projected to be 1.4 billion in 2030 and 2.1 billion in 2050, and could rise to 3.1 billion in 2100. Hence, the increasing global geriatric population is likely to boost the market growth during the forecast period.
The major players operating in the active implantable medical devices market include Abbott, Medtronic, Cochlear Ltd., Boston Scientific Corporation, BIOTRONIK SE&Co, LivaNova PLC, MED-EL, Sonova, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd. and among others. The market players are focused towards bringing new and innovative product launches to sustain their position in the market. For instance, in July, 2017, Cochlear launched its iPhone cochlear implant sound processor. Additionally, in September 2017, Cochlear launched the Baha SoundArc which is the non-surgical bone conduction device.
Technological Advancements and New Product Launches
The active implantable medical devices is an emerging field in the medical industry and has led to various developments of the products, in the field of cardiology, neurology and otology. Many of the market players are developing novel products in order to minimize the burden of cardiovascular diseases, neurological disorders and hearing disorders. For instance, Boston Scientific Corporation in September 2017, launched the Resonate family of Implantable Cardioverter Defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. This product is powered by EnduraLife battery technology, which has double battery capacity as compared to other devices. Thus increasing the longevity of devices and managing heart failure more efficiently.
Increasing Burden of Cardiovascular Diseases, Neurological Disorders and Hearing Disorders
Active implantable devices like pacemakers, cochlear implants, ventricular assist devices, spinal cord stimulators and others are used to treat cardiovascular diseases, neurological disorders and hearing disorders. Thus the increasing prevalence of cardiovascular diseases, neurological disorders and hearing disorders is expected to drive market growth during the forecast period. According to the World health organization in 2017, cardiovascular diseases are number 1 cause of death all over the world. It also mentioned that in 2016, 17.9 million people across the globe died due to cardiovascular diseases.
The report segments the global active implantable medical devices market as follows:
Global Active Implantable Medical Devices Market – By Product
Implantable Cardioverter Defibrillators
Transvenous Implantable Cardioverter Defibrillators
Subcutaneous Implantable Cardioverter Defibrillators
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Implantable Hearing Devices
Global Active Implantable Medical Devices Market – By End User
Ambulatory Surgery Centers
Global Active Implantable Medical Devices Market – By Geography
Asia Pacific (APAC)
Middle East & Africa (MEA)
South and Central America (SCAM)
Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPMD00002232/